Skip to main content
Xlife Sciences AG (SWX:XLS)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
22.10
-0.40 (-1.78%)
At close: Mar 6, 2026

Xlife Sciences AG Revenue

Xlife Sciences AG had revenue of 354.32K CHF in the half year ending June 30, 2025, with 1.82% growth. This brings the company's revenue in the last twelve months to 839.38K, down -15.24% year-over-year. In the year 2024, Xlife Sciences AG had annual revenue of 834.88K, down -15.54%.

Revenue (ttm)
839.38K
Revenue Growth
-15.24%
P/S Ratio
151.85
Revenue / Employee
49.38K
Employees
17
Market Cap
127.46M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024834.88K-153.56K-15.54%
Dec 31, 2023988.44K-39.54K-3.85%
Dec 31, 20221.03M221.91K27.53%
Dec 31, 2021806.07K409.26K103.14%
Dec 31, 2020396.81K-118.02K-22.92%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Partners AG 681.00K
BioVersys AG 1.31M
Santhera Pharmaceuticals Holding AG 49.02M
Newron Pharmaceuticals 55.93M
Basilea Pharmaceutica AG 232.38M
Idorsia 220.58M
Addex Therapeutics 158.54K
Revenue Rankings